Correction to “Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice”

Key Points

• The correction details changes in findings regarding the effect of indolylacetic derivatives.
• Key metric includes the observed impact on tumor necrosis factor levels in the research.
• Subsequent analysis engages with neuroinflammation pathways and ALS mouse models.
• This correction emphasizes the importance of understanding neuroinflammation in ALS for potential therapies.